Michael D. Kinnaman, MD
Pediatric Sarcomas; Rare Tumors; Tumors Resistant to Prior Therapy; Early Phase Clinical Trials; Precision Oncology; Adolescents and Young Adults
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Kinnaman accepts the following list of insurance providers. Select your insurance provider to see more details.
Memorial Sloan Kettering is an in-network provider with Aetna HMO, POS, and PPO plans. Aetna does not include us in any of the plans you can purchase through the insurance exchanges or through Medicare. Please ask your insurance if you need a one-time referral. MSK has an agreement with the Aetna Transplant Program for all Aetna's commercial products.
Memorial Sloan Kettering is a designated Blue Distinction Center for bone marrow transplant and CAR-T.
We understand that there may be many complexities involved with insurance coverage purchased through the health exchange network of the Affordable Care Act. We’re here to help. If you have questions about how your care will be covered by an insurance provider, or need help navigating a change in coverage, please call us at 646-227-3378; if you are not a resident of New York, you can call us at 866-248-1274. Our team is here to listen to your concerns and assist you in any way we can. We want our care to be as accessible and affordable for as many people as possible.
Memorial Sloan Kettering is an in-network provider with CIGNA's HMO, POS, and PPO plans. CIGNA does not include us in any of the plans you can buy through the insurance exchanges.
- If you are a New York State resident: Please ask your insurance if you need a one-time referral.
- If you live outside of New York State: Please ask your insurance if you have in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with EmblemHealth’s PPO, EPO, POS, HMO plans. EmblemHealth includes GHI, HIP, Vytra, and ConnecticCare (in NYS Only). You must bring a referral from your Emblem primary care doctor to your first appointment. In-network participation exceptions include:
- Emblem’s HIP Commercial Millennium, Select Care and Enhanced Care Prime networks is not in-network with Memorial Sloan Kettering.
- Please call Emblem to confirm if your specific plan is in-network.
For information regarding Memorial Sloan Kettering’s participation with Emblem’s Medicare Advantage Plans, please refer to the Medicare & Medicaid page
Memorial Sloan Kettering is an in-network provider with Empire Blue Cross Blue Shield (Wellpoint) of New York Indemnity, HMO, EPO, PPO, POS and Medicare Advantage plans, with the following exceptions:
- Empire Blue Cross Blue Shield does not include us in any of the plans you can buy through the insurance exchanges.
- Please call Empire BCBS to confirm if your specific plan is in-network with Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with HealthFirst’s commercial products; these commercial products are not purchased on the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with HealthSmart’s Accel, HSPC, and HPO networks.
For our NJ locations, Memorial Sloan Kettering is an in-network provider with most Horizon Blue Cross Blue Shield of New Jersey plans for individuals, families, and small businesses. Horizon members with Blue Card Access (there would be a suitcase logo on the front of the card) may have access to our NY locations. Please call Horizon to confirm if your plan is in-network in NY.
Memorial Sloan Kettering is a designated Center of Excellence by Humana.
Memorial Sloan Kettering is a designated Center of Excellence by Interlink Health Services.
Memorial Sloan Kettering is a designated Center of Excellence by Lifetrac.
Memorial Sloan Kettering is an in-network provider for all MagnaCare health plans except those products you can buy through the insurance exchanges.
For information about Medicare and Medicaid, please visit this page
Memorial Sloan Kettering is an in-network provider with some Multiplan/Beech Street/PHCS plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is a designated Center of Excellence by Multiplan.
If you are covered by more than one insurance plan, you will want to determine your benefits from both plans. First, you need to determine which one is your primary insurance provider by contacting your employee benefits office or your insurance carriers. After you find out which is your primary insurance provider, you should then contact your insurance carrier to determine if you have access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with some MVP plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider for New York State employees who have enrolled in UnitedHealthcare's Cancer Resource Services. If you have the Empire Plan, you should call Cancer Resources Services at 866-936-6002 to verify and enroll in this coverage.
Memorial Sloan Kettering is in-network with Oscar’s Circle Plus Network, a part of its Small Group Broad line that is offered only to select small business groups. Oscar does not include Memorial Sloan Kettering as an in-network provider for any of its individual plans. Please confirm eligibility with your insurance carrier.
Most Blue Cross Blue Shield plans include Memorial Sloan Kettering as an in-network provider. Contact your insurance company to confirm if Memorial Sloan Kettering is in-network.
We have agreements with several insurance companies that may provide additional coverage for cancer patients. These benefit programs include:
- AXA Assistance USA
- Beech Street
- Integrated Health Plans
- National Health Administrators
- National Preferred Provider Network
- UnitedHealthcare's Cancer Resource Services
- United Resource Network
- Veterans Choice Program
Memorial Sloan Kettering is an in-network provider with Oxford’s Freedom and Liberty plans as well as the Metro Plan (which is only offered to small business groups and no longer offered as individual plans). Please confirm with your insurance if you need a one-time referral. Note: Oxford’s Medicare Managed Care plan — Secure Horizon — does not include Memorial Sloan Kettering as an in-network provider. Oxford does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with the World Trade Center Health Program.
Memorial Sloan Kettering is an in-network provider with QualCare's PPO and HMO/POS network.
Memorial Sloan Kettering is a designated Center of Excellence by Specialty Care Management.
Hospital and physician services may be covered by TRICARE. Please call your TRICARE plan to confirm coverage at Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with UnitedHealthCare's HMO, POS, and PPO plans. Please confirm with your insurance if a one-time referral is needed.
UnitedHealthCare's Medicare Managed Care plan does not include Memorial Sloan Kettering as an in-network provider.
United does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is a designated Center of Excellence by UnitedHealthcare.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, Stony Brook School of Medicine
Pediatrics - Children’s Hospital at Montefiore
Pediatric Hematology/Oncology - Memorial Sloan Kettering Cancer Center/NewYork-Presbyterian/Weill Cornell Medical Center
Pediatric; Pediatric Hematology/Oncology
I am a pediatric oncologist on the MSK Kids team who works with children and young adults with solid tumors. I specialize in the treatment of tumors in the bones and soft tissues, including osteosarcoma, Ewing sarcoma, rhabdomyosarcoma, and other rare sarcomas. It is a tremendous responsibility to care for children, young adults, and their families throughout the challenging and unpredictable journey that comes with a cancer diagnosis. However, I pride myself in lending a steady hand, compassion, and unwavering enthusiasm as I help guide our patients and their families through this process.
As a proud member of the MSK Kids Pediatric Sarcoma team, I see myself as the “quarterback” of a patient’s care experience. I form a treatment plan that is unique to the needs of each patient, with input and consensus drawn from our team of physicians, advanced practice providers, nurses, pharmacists, social workers, and support staff, who have unparalleled experience and clinical expertise in treating pediatric sarcomas.
I am passionate not only about working with children but also with adolescent and young adult (AYA) patients. AYA patients are often at a crossroads in life, and a cancer diagnosis can be a major disruption to their career and life plans. With our dedicated group of specialists in AYA patient care, we are committed to getting our patients through treatment and back to pursuing their hopes and dreams.
Although I treat many types of solid tumors at Memorial Sloan Kettering Cancer Center (MSK), I am especially interested in the management of osteosarcoma or Ewing sarcoma that is either resistant to initial treatment or returns after a period of remission. Determining the next best option for a patient is a very individualized decision, impacted by the biology and genomics of their tumor, extent of their disease, past treatment history, and personal and family values. Helping families navigate these difficult decisions and providing recommendations and treatment options that take into account the many factors that make each patient unique is where we excel here at MSK Kids.
In addition to caring for patients, I conduct research focused on how cancer can change and adapt over time, moving beyond the original site of disease to other organs. My research specifically focuses on studying different types of pediatric sarcomas, with two active projects studying cancer evolution in both osteosarcoma and rhabdomyosarcoma. My goal is to characterize the tumor cells that are resistant to our current therapy. To do so, my research team and I are using whole-genome sequencing, which allows us to map out the entire genetic code of a cancer cell, on patients’ tumor samples at different time points throughout treatment. We then compare the genetic makeup of each sample to the genetic makeup of the samples collected at an earlier time in a patient’s treatment plan to see how the tumor has changed. This allows us to not only identify the resistant tumor cells but also to characterize and describe their genetic makeup. We hope that this information will lead to new therapies and treatment strategies targeted at these resistant tumor cells, improving outcomes for our patients with pediatric sarcomas.
Awards and Honors
- Conquer Cancer Foundation of ASCO/What Would Willie Want (Quad W) Foundation Young Investigator Award (2019)
- Hyundai Hope on Wheels, Young Investigator Award (2019)
- Rally Foundation Young Investigator Award (2020)
- National Institutes of Health, Memorial Sloan Kettering Cancer Center, K12 Paul Calabresi Career Development Award for Clinical Oncology (2020)
- Junior Faculty Council Member (2020)
- Clinical Trials Investigated by Dr. Kinnaman
- A Phase II Study of Olaparib plus Ceralasertib in People with Recurrent Osteosarcoma
- Clinical Trials Co-Investigated by Dr. Kinnaman
- A Phase I Study of CLR 131 in Children, Adolescents, and Young Adults with Recurrent or Persistent Solid Tumors, Lymphoma, and Brain Tumors
- A Phase II Study of Hu3F8 plus GM-CSF to Prevent Osteosarcoma Recurrence
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Visit PubMed for a full listing of Dr. Kinnaman’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.